FDA Expands Zepbound Label To Allow Use With Eli Lilly’s KwikPen

from TheBrief.Health · host TheBrief.Health

FDA updates Zepbound labeling, pairing tirzepatide with KwikPen for weight management and cardiovascular risk reduction, improving usability, adherence, and access for patients, clinicians, pharmacies, and healthcare systems.

Episode metadata supplied by the publisher feed · Published Apr 23, 2026

Embed this episode

Attribution link and audio player

NOW PLAYING

FDA Expands Zepbound Label To Allow Use With Eli Lilly’s KwikPen

0:00 1:54

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of TheBrief.Health?

This episode is 1 minute long.

When was this TheBrief.Health episode published?

This episode was published on April 23, 2026.

Can I download this TheBrief.Health episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!